BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31073906)

  • 1. Depression and antidepressant action-from molecules to networks.
    Rantamäki T; Yalcin I
    Cell Tissue Res; 2019 Jul; 377(1):1-4. PubMed ID: 31073906
    [No Abstract]   [Full Text] [Related]  

  • 2. A brief history of antidepressant drug development: from tricyclics to beyond ketamine.
    Pereira VS; Hiroaki-Sato VA
    Acta Neuropsychiatr; 2018 Dec; 30(6):307-322. PubMed ID: 29388517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of copper and ketamine in major depressive disorder - an update.
    Słupski J; Słupska A; Szałach ŁP; Włodarczyk A; Górska N; Szarmach J; Jakuszkowiak-Wojten K; Gałuszko-Węgielnik M; Wilkowska A; Wiglusz MS; Cubała WJ
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):520-523. PubMed ID: 31488784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A review of the antidepressant properties of ketamine].
    Desfossés CY; Blier P
    Med Sci (Paris); 2021 Jan; 37(1):27-34. PubMed ID: 33492215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine for Treatment-Resistant Depression: a New Advocate.
    Pérez-Esparza R
    Rev Invest Clin; 2018; 70(2):65-7. PubMed ID: 29718013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine.
    Chaki S; Fukumoto K
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The positive effect on ketamine as a priming adjuvant in antidepressant treatment.
    Melo A; Kokras N; Dalla C; Ferreira C; Ventura-Silva AP; Sousa N; Pêgo JM
    Transl Psychiatry; 2015 May; 5(5):e573. PubMed ID: 26080090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of mTOR in depression and antidepressant responses.
    Abelaira HM; Réus GZ; Neotti MV; Quevedo J
    Life Sci; 2014 Apr; 101(1-2):10-4. PubMed ID: 24582593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapeutic strategies in major depression: focus on RNAi and ketamine.
    Bortolozzi A; Celada P; Artigas F
    Curr Pharm Des; 2014; 20(23):3848-60. PubMed ID: 24180396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoaminergic system and depression.
    Perez-Caballero L; Torres-Sanchez S; Romero-López-Alberca C; González-Saiz F; Mico JA; Berrocoso E
    Cell Tissue Res; 2019 Jul; 377(1):107-113. PubMed ID: 30627806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid-onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression.
    Drewniany E; Han J; Hancock C; Jones RL; Lim J; Nemat Gorgani N; Sperry JK; Yu HJ; Raffa RB
    J Clin Pharm Ther; 2015 Apr; 40(2):125-30. PubMed ID: 25545040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Mechanisms of Ketamine.
    Mihaljević S; Pavlović M; Reiner K; Ćaćić M
    Psychiatr Danub; 2020; 32(3-4):325-333. PubMed ID: 33370729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rapid-onset antidepressant effect of ketamine: More surprises?
    Raffa RB; Pergolizzi JV; Taylor R;
    J Clin Pharm Ther; 2018 Apr; 43(2):308-311. PubMed ID: 29178131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid antidepressant effects of ketamine ignite drug discovery.
    Dolgin E
    Nat Med; 2013 Jan; 19(1):8. PubMed ID: 23295995
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid anti-depressant-like effects of ketamine and other candidates: Molecular and cellular mechanisms.
    Peng FZ; Fan J; Ge TT; Liu QQ; Li BJ
    Cell Prolif; 2020 May; 53(5):e12804. PubMed ID: 32266752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant effects of ketamine in depressed patients.
    Berman RM; Cappiello A; Anand A; Oren DA; Heninger GR; Charney DS; Krystal JH
    Biol Psychiatry; 2000 Feb; 47(4):351-4. PubMed ID: 10686270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA antagonists under investigation for the treatment of major depressive disorder.
    Pochwat B; Pałucha-Poniewiera A; Szewczyk B; Pilc A; Nowak G
    Expert Opin Investig Drugs; 2014 Sep; 23(9):1181-92. PubMed ID: 24818801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocyte Specific Remodeling of Plasmalemmal Cholesterol Composition by Ketamine Indicates a New Mechanism of Antidepressant Action.
    Lasič E; Lisjak M; Horvat A; Božić M; Šakanović A; Anderluh G; Verkhratsky A; Vardjan N; Jorgačevski J; Stenovec M; Zorec R
    Sci Rep; 2019 Jul; 9(1):10957. PubMed ID: 31358895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of NMDA receptors in the treatment of major depression.
    Dang YH; Ma XC; Zhang JC; Ren Q; Wu J; Gao CG; Hashimoto K
    Curr Pharm Des; 2014; 20(32):5151-9. PubMed ID: 24410564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.